Skip to product information
1 of 1

TRE HOUSE BARS 7OHM 7-HYDROXY + PSEUDO RAPID RELEASE TABLETS 4CT 70MG PER TABLET

TRE HOUSE BARS 7OHM 7-HYDROXY + PSEUDO RAPID RELEASE TABLETS 4CT 70MG PER TABLET

Regular price $29.95 USD
Regular price Sale price $29.95 USD

$7.49 per Tab

$0.11 per Mg

Sale Sold out
Taxes included. Shipping calculated at checkout.
Flavor

Secured checkout with

  • American Express
  • Diners Club
  • Discover
  • Google Pay
  • JCB
  • Visa
  • Bar chart with an upward trend arrow and a check mark, indicating success or approval.

    Quality & Value

    Best Competitive Pricing Anywhere

  • Icon of a box with a document and an arrow, symbolizing downloading or receiving a document.

    Fast Fulfillment

    We Pack In Hours Mon thru Sat

  • Black shield icon with a check mark on a white background

    Safe Payment

    Secure Checkout with Visa/MC

View full details

DESCRIPTION

Premium 70mg Rapid Release Tablets with 7 Hydroxymitragynine + Pseudo Indoxyl Blend

Experience the next evolution in kratom supplementation with TRE House Bars 7OHM Rapid Release Tablets. Each powerful tablet combines 60mg of pure 7-hydroxymitragynine with 10mg of pseudo indoxyl for a synergistic 70mg total alkaloid blend. This 4-count package delivers 280mg of premium kratom compounds with advanced rapid release technology.

Advanced Dual-Alkaloid Formula - 60mg 7-Hydroxymitragynine + 10mg Pseudo Indoxyl

TRE House Bars 7OHM features an innovative dual-alkaloid formulation that combines the potent effects of 7-hydroxymitragynine with the unique properties of pseudo indoxyl. This scientifically-designed blend offers enhanced bioavailability and optimized effects for experienced kratom enthusiasts.

What Makes TRE House Bars 7OHM Unique?

Unlike standard kratom tablets, TRE House Bars 7OHM utilizes a synergistic dual-alkaloid approach combining two powerful compounds:

  • 7-Hydroxymitragynine (60mg): The most potent naturally-occurring kratom alkaloid, known for its powerful effects
  • Pseudo Indoxyl (10mg): A complementary alkaloid that enhances the overall experience and bioavailability

Rapid Release Technology - Faster Onset, Better Results

TRE House's proprietary Rapid Release formula is engineered for enhanced absorption and quicker onset times compared to standard kratom tablets. This advanced delivery system ensures you experience the full benefits of both alkaloids efficiently and effectively.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)

WARNING: This product contains 7-Hydroxymitragynine (7-OH) and should always be used responsibly and only as directed. Keep Out of Reach of Children. This product is not intended to diagnose, treat, cure, or prevent any medical condition or disease and may be harmful to your health. FDA has not approved 7OH for therapeutic uses. Consult a health provider for questions regarding 7OH use. Do not use this product: (1) if the product is damaged or has been opened prior to use; (2) in combination with any psychoactive, intoxicating or impairing substance including other botanical products , alcohol, nicotine, cannabinoids, or illicit substances; (3) if you have health conditions (including but not limited to any heart or liver disease or disorder, or high blood pressure) or use prescription medicine, over-the-counter drugs or dietary supplements except under physician supervision; (4) if you are pregnant, may become pregnant, or are breastfeeding; or (5) before engaging in dangerous activities, operating machinery or operating a motor vehicle. This product is not intended to be used or sold as an alternative to alcohol, nicotine, cannabinoids, prescription medications, or any other substance.  This product is not intended to be used or sold for the treatment of any disease, illness or injury for which physician care should be sought.  7OH may be habit forming. If you struggle with addiction or dependency or have questions regarding 7OH, consult a physician before using this product. If you experience any adverse effects from using this product, seek immediate medical attention.


These statements have not been evaluated by the United States Food and Drug Administration.